Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
..still pounding the pavement for Zenith finding a partner? (Have heard about six prospective suiters for several years now...maybe 2022 is our year?)